Equillium receives Nasdaq extension to Dec 8, 2025 for bid price compliance

Equillium, Inc.

Nasdaq granted Equillium (EQ) until Dec 8, 2025 to regain minimum $1.00 bid price compliance.
Original 180-day compliance period ended June 11, 2025; extension provides additional 180 calendar days.
If not compliant by Dec 8, 2025, staff will issue delisting notice; company may appeal to hearings panel.
Company will monitor bid price and consider reverse stock split or other options to regain compliance.
Stock continues trading on Nasdaq Capital Market under symbol EQ; no immediate delisting effect.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.